CareDx
CDNA
$10.28
Share price
5.76%
Change (1 day)
22.53%
Change (1 year)
P/S ratio for CareDx (CDNA)
P/S ratio as of May 2024 (TTM): 1.80
According to CareDx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.80334. At the end of 2023 the company had a P/S ratio of 2.32.
P/S ratio history for CareDx from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.32 | 21.99% |
| 2022 | 1.90 | -76.57% |
| 2021 | 8.10 | -56.37% |
| 2020 | 18.6 | 157.38% |
| 2019 | 7.21 | -46.91% |
| 2018 | 13.6 | 212.75% |
| 2017 | 4.34 | 207.28% |
| 2016 | 1.41 | -47.76% |
| 2015 | 2.71 | -13.64% |
| 2014 | 3.13 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 T2 Biosystems
TTOO | 4.55 | 152.17% | 🇺🇸 USA |
 Agios Pharmaceuticals
AGIO | 73.1 | 3,953.96% | 🇺🇸 USA |
 Invitae
NVTA | 0.0116 | -99.36% | 🇺🇸 USA |